LRG annual holiday fundraiser going strong!
If you have been mailed a fundraising packet and still have donor cards to send out, it is not too late. Consider passing one on to a neighbor co-worker, friend or family member.
LRG Sets GDOL Miami Date for March
The second annual GIST Day of Learning will be held on March 23, 2013. This year we are privileged once again that Dr. Jonathan Trent of Sylvester Cancer Center in Miami has agreed to host our gathering and we are honored to hear what he has to say.
LRG welcomes Deputy Director and two new members to Board
The LRG is pleased to welcome Roger C. Campbell as our new Deputy Director. Roger, an attorney, brings to the LRG over 25 years of experience in the global financial services sector.
LRG launches new & improved website, convenient mobile app & online store!
After two years of planning, toiling, and more planning, the LRG unveiled its redesigned website on January 1 at our same web address: liferaftgroup.org. Finding the balance between providing life-saving information and explaining GIST in a concise, understandable way, has always been a struggle for the Life Raft Group.
LRG Research Team holds quarterly meeting
The LRG Research Team recently held a teleconference that focused primarily on a study the team will collaborate on and intends to publish.
Personalized medicine: is it myth or reality?
Executive Director’s report focuses on better treatment options for GISTers For my Executive Director’s report, I usually highlight the many accomplishments of the Life Raft Group. Some of which include: Launching a GIST Day [...]
LRG & colleagues make their mark on 17th annual CTOS meeting in Prague
Representatives from the Life Raft Group recently traveled to Prague, Czech Republic to attend the annual Connective Tissue Oncology Society (CTOS) meeting. CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues.
Patients Face Numerous Obstacles In Quest For Life-Saving Treatment
“It was such a frustrating time. It was awful,” Linda says, recalling how doctors had recommended she give Glaxo-SmithKline’s drug Votrient a shot but was unable to get Jessica’s insurance company to cover it despite appeals documented by GIST specialists.
Lon Garber’s Excellent Adventure: facing Gollum, P.T. & Paul Simon with R2D2
Lon Garber It all began in Africa with a pain in my backside. My wife, Val, jokingly called it payback time since I’d been a pain in her backside for 37 years. The [...]
LRG Research Team members publish results of imatinib combination study
Drs. Jonathan Fletcher, of Brigham & Women’s Hospital, Harvard University and Maria Debiec-Rychter, of the Catholic University in Leuven, Belgium, members of the LRG Research Team were part of a recently published study that looked at the effectiveness of GDC-0941, a PI3K inhibitor when used in combination with imatinib (Gleevec).